PERSPECTA

News from every angle

← Back to headlines

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

24 Feb, 20:38 — 24 Feb, 20:38
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha3d ago

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

Read full article →

Related Stories

LTFRB suspends 3 transport network firms for violations

just now

Paramount-Skydance to Acquire Warner Bros. Discovery

30m ago

Trade parleys with US evolving, have room to ‘rebalance’: Piyush Goyal

35m ago

India and EU to Grant Each Other Most Favoured Nation Status

41m ago